Eliem Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $4.7k | 1.7k | 2.74 |
| 2023-09-30 | $4.5k | 1.7k | 2.63 |
| 2023-06-30 | $4.8k | 1.7k | 2.80 |
| 2022-12-31 | $531 | 145 | 3.67 |
| 2022-06-30 | $28k | 6.6k | 4.26 |
| 2022-03-31 | $0 | 5.7k | 0.00 |